Literature DB >> 15280538

Translocation of CD28 to lipid rafts and costimulation of IL-2.

Ali Sadra1, Tomas Cinek, John B Imboden.   

Abstract

Stimulation of the CD28 costimulatory receptor can lead to an increased surface lipid raft expression in T lymphocytes. Here, we demonstrate that CD28 itself is recruited to lipid rafts in both Jurkat and peripheral blood T lymphocytes. This recruitment of CD28 is triggered by engagement with either anti-CD28 mAbs or a natural ligand of CD28, B7.2 (CD86). All detectable tyrosine-phosphorylated CD28 is in the lipid raft fractions, as is all of the CD28 associated with phosphatidylinositol 3-kinase, which is recruited to CD28 by tyrosine phosphorylation. Targeting the CD28 cytoplasmic domain to lipid rafts results in its tyrosine phosphorylation, indicating that tyrosine phosphorylation of CD28 may occur after translocation to lipid rafts. Studies with Jurkat cells deficient in Lck and CD45 demonstrate that movement of CD28 into lipid rafts does not require Lck and CD45 and can occur despite reduction of CD28 tyrosine phosphorylation to below the levels of detection. Analysis of murine CD28 mutants reveals a correlation between translocation to lipid rafts and costimulation of IL-2 production. Taken together with the known importance of lipid rafts in T cell activation, these observations suggest that translocation to lipid rafts may play an important role in CD28 signaling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15280538      PMCID: PMC509216          DOI: 10.1073/pnas.0403792101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Negative-feedback regulation of CD28 costimulation by a novel mitogen-activated protein kinase phosphatase, MKP6.

Authors:  F Marti; A Krause; N H Post; C Lyddane; B Dupont; M Sadelain; P D King
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

2.  Tyrosine phosphatase SHP-2 binding to CTLA-4: absence of direct YVKM/YFIP motif recognition.

Authors:  H Schneider; C E Rudd
Journal:  Biochem Biophys Res Commun       Date:  2000-03-05       Impact factor: 3.575

3.  Non-CD28 costimulatory molecules present in T cell rafts induce T cell costimulation by enhancing the association of TCR with rafts.

Authors:  Y Yashiro-Ohtani; X Y Zhou; K Toyo-Oka; X G Tai; C S Park; T Hamaoka; R Abe; K Miyake; H Fujiwara
Journal:  J Immunol       Date:  2000-02-01       Impact factor: 5.422

4.  The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A.

Authors:  E Chuang; T S Fisher; R W Morgan; M D Robbins; J M Duerr; M G Vander Heiden; J P Gardner; J E Hambor; M J Neveu; C B Thompson
Journal:  Immunity       Date:  2000-09       Impact factor: 31.745

5.  Dynamic recruitment of human CD2 into lipid rafts. Linkage to T cell signal transduction.

Authors:  H Yang; E L Reinherz
Journal:  J Biol Chem       Date:  2001-02-28       Impact factor: 5.157

Review 6.  GPI-microdomains: a role in signalling via immunoreceptors.

Authors:  V Horejsí; K Drbal; M Cebecauer; J Cerný; T Brdicka; P Angelisová; H Stockinger
Journal:  Immunol Today       Date:  1999-08

7.  Essential role of CD8 palmitoylation in CD8 coreceptor function.

Authors:  A Arcaro; C Grégoire; N Boucheron; S Stotz; E Palmer; B Malissen; I F Luescher
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

Review 8.  CD28 costimulation: a source of Vav-1 for TCR signaling with the help of SLP-76?

Authors:  Frédérique Michel; Oreste Acuto
Journal:  Sci STKE       Date:  2002-08-06

9.  Lipid raft distribution of CD4 depends on its palmitoylation and association with Lck, and evidence for CD4-induced lipid raft aggregation as an additional mechanism to enhance CD3 signaling.

Authors:  Roben Fragoso; Dejian Ren; Xiaoping Zhang; Michael Wei-Chih Su; Steven J Burakoff; Yong-Jiu Jin
Journal:  J Immunol       Date:  2003-01-15       Impact factor: 5.422

10.  Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor.

Authors:  P W Janes; S C Ley; A I Magee
Journal:  J Cell Biol       Date:  1999-10-18       Impact factor: 10.539

View more
  7 in total

1.  OX40 complexes with phosphoinositide 3-kinase and protein kinase B (PKB) to augment TCR-dependent PKB signaling.

Authors:  Takanori So; Heonsik Choi; Michael Croft
Journal:  J Immunol       Date:  2011-02-02       Impact factor: 5.422

Review 2.  Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells.

Authors:  Hélène Bour-Jordan; Jeffrey A Bluestone
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

3.  Combinatorial signals from CD28 differentially regulate human immunodeficiency virus transcription in T cells.

Authors:  Malini Natarajan; Avery August; Andrew J Henderson
Journal:  J Biol Chem       Date:  2010-04-05       Impact factor: 5.157

4.  Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages.

Authors:  Lesley E Smythies; C Roger White; Akhil Maheshwari; M N Palgunachari; G M Anantharamaiah; Manjula Chaddha; Ashish R Kurundkar; Geeta Datta
Journal:  Am J Physiol Cell Physiol       Date:  2010-03-10       Impact factor: 4.249

5.  High molecular weight complex analysis of Epstein-Barr virus Latent Membrane Protein 1 (LMP-1): structural insights into LMP-1's homo-oligomerization and lipid raft association.

Authors:  Christopher M Wrobel; Timothy R Geiger; Rebecca N Nix; Aaron M Robitaille; Sandra Weigand; Alfredo Cervantes; Miguel Gonzalez; Jennifer M Martin
Journal:  Virus Res       Date:  2013-09-25       Impact factor: 3.303

6.  Signals and sequences that control CD28 localization to the central region of the immunological synapse.

Authors:  Mariano Sanchez-Lockhart; Beth Graf; Jim Miller
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

7.  CD80 and CD86 differentially regulate mechanical interactions of T-cells with antigen-presenting dendritic cells and B-cells.

Authors:  Tong Seng Lim; James Kang Hao Goh; Alessandra Mortellaro; Chwee Teck Lim; Günter J Hämmerling; Paola Ricciardi-Castagnoli
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.